Research Article

Safety Assessment of Ubiquinol Acetate: Subchronic Toxicity and Genotoxicity Studies

Table 10

Effect of ubiquinol acetate on clinical chemistry parameters in female rats.

ParametersUnitsGroup & Dose (mg/kg b.w.)
G1,G2, G3, G4,G1R, G4R,
0150300 6000 600

Glucosemg/dL124.50±25.44105.90±17.91116.3±12.03111.40±12.61122.2±8.11116.20±9.78

Blood Urea Nitrogenmg/dL18.20±2.3019.50±2.2220.50±3.4421.30±3.8311.20±3.9613.20±2.77

Creatininemg/dL0.46±0.100.44±0.070.49±0.100.49±0.050.27±0.020.34±0.05

Cholesterolmg/dL86.70±18.7891.60±17.9987.40±22.8090.20±19.87103.40±9.86120.20±23.83

TGLmg/dL31.90±11.9434.90±5.5931.20±7.9434.10±8.1831.80±9.2025.60±4.93

Total Proteing/dL6.92±0.397.02±0.376.78±0.277.16±0.466.66±0.266.66±0.48

Albuming/dL1.53±0.161.56±0.131.41±0.131.47±0.301.40±0.191.12±0.19

Total Bilirubinmg/dL0.11±0.060.08±0.090.07±0.050.11±0.060.10±0.070.06±0.05

ASTU/L71.10±15.0787.80±34.7889.80±19.10118.20±42.6570.60±16.0482.00±12.88

Calciummg/dL9.80±0.399.90±0.229.39±0.289.28±1.669.02±0.319.20±0.33

Phosphorusmg/dL5.24±0.674.99±0.475.44±0.535.28±0.485.10±0.315.22±0.28

ALPU/L64.30±11.4566.40±16.1377.20±15.4083.30±33.6840.00±10.5645.60±4.88

ALTU/L13.10±2.6020.30±6.4823.10±6.6131.30±14.6716.60±3.0521.80±2.95

GGTU/L2.40±1.262.30±1.343.00±0.822.20±1.485.40±1.345.20±1.30

Sodiummmol/L135.14±1.78135.84±1.55135.18±1.56136.30±2.02137.52±0.76136.92±0.36

Potassiummmol/L4.00±0.343.76±0.243.87±0.303.87±0.274.16±0.254.11±0.33

Chloridemmol/L107.81±1.41107.77±1.38107.23±1.27108.72±1.62107.60±0.74107.58±0.86

Globuling/dL5.35±0.325.46±0.335.35±0.225.69±0.355.26±0.185.54±0.47

Mean ± SD for 10 rats/sex/group (G1, G2, G3, G4) and 5 rats/sex/group (G1R, G4R); : statistically significant compared to the control group (p < 0.05).